title: Prevention of venous thromboembolism after surgery: a review of enoxaparin.
abstract: This review discusses the problem of deep vein thrombosis (DVT) after operation and identifies three levels of risk of DVT: low (less than 10 per cent), moderate (10-40 per cent) and high (40-80 per cent). Special emphasis is placed on the most recent prophylactic treatment, low molecular weight heparins (LMWHs), particularly enoxaparin. Several LMWHs are now available, but they differ slightly and each must be evaluated on its own merits. In general, however, LMWHs are both effective and safe in those patients at moderate or high risk of DVT. Thromboprophylaxis is cost effective when analysed using health-economic methodology.
authors.affiliation: Malmö General Hospital, Sweden.
authors.forename: D
authors.initials: D
authors.lastname: Bergqvist
authors.forename: G D
authors.initials: GD
authors.lastname: Lowe
authors.forename: A
authors.initials: A
authors.lastname: Berstad
authors.forename: S
authors.initials: S
authors.lastname: Haas
authors.forename: J
authors.initials: J
authors.lastname: Hirsh
authors.forename: M R
authors.initials: MR
authors.lastname: Lassen
authors.forename: M
authors.initials: M
authors.lastname: Samama
authors.forename: R
authors.initials: R
authors.lastname: Verhaeghe
mesh_terms: D000328:Adult; D000368:Aged; D003362:Cost-Benefit Analysis; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D006495:Heparin, Low-Molecular-Weight